undamentalytics Newsletter
Sign in

Integra Lifesciences Holdings Corp revenue

Integra Lifesciences Holdings Corp's revenue was $1.64bn in fiscal 2025, up 1.5% on the year before. Since fiscal 2009 ($682m) it has grown at a compound 5.6% a year. Over the last twelve months it was $1.66bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue6827327808316977978839921,1881,4721,5181,3721,5421,5581,5421,6111,6351,657
Growth on the year before—+7.3%+6.6%+6.5%−16.1%+14.3%+10.8%+12.4%+19.8%+23.9%+3.1%−9.6%+12.4%+1.0%−1.0%+4.5%+1.5%—
Gross profit—————494556643753901953851945970885882832867
Gross margin—————62.0%63.0%64.8%63.3%61.2%62.8%62.0%61.2%62.3%57.4%54.8%50.9%52.4%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Codman Specialty Surgical $1.2B 73.4% ▲ 5.0%
Tissue Technologies $435M 26.6% ▼ 6.9%
Geography
Region Revenue Share YoY
United States $1.2B 73.7% ▲ 1.0%
Asia Pacific $189M 11.6% ▲ 7.2%
Europe $163M 9.9% ▲ 2.6%
Rest of The World $78.6M 4.8% ▼ 5.0%

From Integra Lifesciences Holdings Corp's 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Integra Lifesciences Holdings Corp $1.66bn 0.8% 2.4%
Merit Medical Systems Inc $1.61bn 9.1% 9.5%
Penumbra Inc $1.56bn 17.0% 16.2%
Integer Holdings Corp $1.83bn -0.3% 6.7%
Haemonetics Corp $1.35bn 0.4% 3.5%
Stevanato Group S.p.a. $1.34bn 12.3% —

Compare with peers

Head to head: IART vs MMSIIART vs PENIART vs ITGR

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Integra Lifesciences Holdings Corp's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Integra Lifesciences Holdings Corp.